Thyroid Hormone Synthesis

Clinical Management of Thyroid Disease

Volumn , Issue , 2009, Pages 19-41

  Kopp, Peter ^a   Solis S, Juan Carlos ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSIDAD AUTÓNOMA DE QUERÉTARO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79951874535     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-4745-2.00003-1     Document Type: Chapter

References (287)

1. P. Kopp (2005) Thyroid hormone synthesis: Thyroid iodine metabolism. L. Braverman, R. Utiger (Eds) Werner and Ingbar’s The Thyroid: A Fundamental and Clinical Text Philadelphia, Lippincott: Williams & Wilkins 52-76
2. A. Taurog (2005,) Hormone synthesis: Thyroid iodine metabolism. L. Braverman, R. Utiger (Eds) Werner and Ingbar’s The Thyroid: A Fundamental and Clinical Text Philadelphia, Lippincott: Williams & Wilkins 61-85
3. J. Dunn (2001) Biosynthesis and secretion of thyroid hormones. L. De Groot, J. Jameson (Eds) Endocrinology Philadelphia: WB Saunders 1290-1300
4. J. Wolff (1964) Transport of iodide and other anions in the thyroid gland. Physiol Rev 44 45-90
5. A. De La Vieja, O. Dohan, O. Levy and N. Carrasco (2000) Molecular analysis of the sodium/iodide symporter: Impact on thyroid and extrathyroid pathophysiology. Physiol Rev 80 1083-1105
6. O. Dohan, A. De la Vieja, V. Paroder, et al. (2003) The sodium/iodide symporter (NIS): Characterization, regulation, and medical significance. Endocr Rev 24 48-77
7. G. Dai, O. Levy and N. Carrasco (1996) Cloning and characterization of the thyroid iodide transporter. Nature 379 458-460
8. P.A. Smanik, Q. Liu, T.L. Furminger, et al. (1996) Cloning of the human sodium iodide symporter. Biochem Biophys Res Commun 226 339-345
9. P.A. Smanik, K.Y. Ryu, K.S. Theil, et al. (1997) Expression, exon-intron organization, and chromosome mapping of the human sodium iodide symporter. Endocrinology 138 3555-3558
10. O. Levy, G. Dai, C. Riedel, et al. (1997) Characterization of the thyroid Na +/I − symporter with an anti-COOH terminus antibody. Proc Natl Acad Sci U S A 94 5568-5573
11. O. Levy, A. De la Vieja, C.S. Ginter, et al. (1998) N-linked glycosylation of the thyroid Na +/I − symporter (NIS). Implications for its secondary structure model. J Biol Chem 273 22657-22663
12. S.J. Weiss, N.J. Philp and E.F. Grollman (1984) Iodide transport in a continuous line of cultured cells from rat thyroid. Endocrinology 114 1090-1098
13. S. Eskandari, D.D. Loo, G. Dai, et al. (1997) Thyroid Na +/I − symporter. Mechanism, stoichiometry, and specificity. J Biol Chem 272 27230-27238
14. H.M. Barker (1936) The blood cyanates in the treatment of hypertension. JAMA 106 762-767
15. T.E. Hilditch, P.W. Horton, D.C. McCruden, et al. (1982) Defects in intrathyroid binding of iodine and the perchlorate discharge test. Acta Endocrinol (Copenh) 100 237-244
16. J. Van Sande, C. Massart, R. Beauwens, et al. (2003) Anion selectivity by the sodium iodide symporter. Endocrinology 144 247-252
17. O. Dohan, C. Portulano, C. Basquin, et al. (2007) The Na +/I symporter (NIS) mediates electroneutral active transport of the environmental pollutant perchlorate. Proc Natl Acad Sci U S A 104 20250-20255
18. P. Kopp (2002) Perspective: Genetic defects in the etiology of congenital hypothyroidism. Endocrinology 143 2019-2024
19. J.C. Moreno, H. Bikker, M.J. Kempers, et al. (2002) Inactivating mutations in the gene for thyroid oxidase 2 (THOX2) and congenital hypothyroidism. N Engl J Med 347 95-102
20. I. Zamproni, H. Grasberger, F. Cortinovis, et al. (2008) Biallelic Inactivation of the Dual Oxidase Maturation Factor 2 (DUOXA2) gene as a novel cause of congenital hypothyroidism. J Clin Endocrinol Metab 93 605-610
21. S.J. Weiss, N.J. Philp, F.S. Ambesi-Impiombato and E.F. Grollman (1984) Thyrotropin-stimulated iodide transport mediated by adenosine 3¢,5¢-monophosphate and dependent on protein synthesis. Endocrinology 114 1099-1107
22. G. Vassart and J.E. Dumont (1992) The thyrotropin receptor and the regulation of thyrocyte function and growth. Endocr Rev 13 596-611
23. G. Vassart, J. Parma, J. van Sande and J.E. Dumont (1994) The thyrotropin receptor and the regulation of thyrocyte function and growth: Update 1994. L.E. Braverman, S. Refetoff (Eds) Endocrine Review Monographs Bethesda, Md: Endocrine Society 77-80
24. T. Kogai, T. Endo, T. Saito, et al. (1997) Regulation by thyroid-stimulating hormone of sodium/iodide symporter gene expression and protein levels in FRTL-5 cells. Endocrinology 138 2227-2232
25. T. Saito, T. Endo, A. Kawaguchi, et al. (1997) Increased expression of the Na +/I − symporter in cultured human thyroid cells exposed to thyrotropin and in Graves’ thyroid tissue. J Clin Endocrinol Metab 82 3331-3336
26. T. Kogai, F. Curcio, S. Hyman, et al. (2000) Induction of follicle formation in long-term cultured normal human thyroid cells treated with thyrotropin stimulates iodide uptake but not sodium/iodide symporter messenger RNA and protein expression. J Endocrinol 167 125-135
27. C. Riedel, O. Levy and N. Carrasco (2001) Post-transcriptional regulation of the sodium/iodide symporter by thyrotropin. J Biol Chem 276 21458-21463
28. J. Wolff and I. Chaikoff (1948) Plasma inorganic iodide as homeostatic regulator of thyroid function. J Biol Chem 174 555-564
29. J. Wolff, I. Chaikoff, R. Goldberg and J. Meier (1949) The temporary nature of the inhibitory action of excess iodide on organic iodide synthesis in the normal thyroid. Endocrinology 45 504-513
30. E.F. Grollman, A. Smolar, A. Ommaya, et al. (1986) Iodine suppression of iodide uptake in FRTL-5 thyroid cells. Endocrinology 118 2477-2482
31. L.E. Braverman and S.H. Ingbar (1963) Changes in thyroidal function during adaptation to large doses of iodide. J Clin Invest 42 1216-1231
32. N. Uyttersprot, N. Pelgrims, N. Carrasco, et al. (1997) Moderate doses of iodide in vivo inhibit cell proliferation and the expression of thyroperoxidase and Na +/I − symporter mRNAs in dog thyroid. Mol Cell Endocrinol 131 195-203
33. C. Spitzweg, W. Joba, J.C. Morris and A.E. Heufelder (1999) Regulation of sodium iodide symporter gene expression in FRTL-5 rat thyroid cells. Thyroid 9 821-830
34. P.H. Eng, G.R. Cardona, S.L. Fang, et al. (1999) Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein. Endocrinology 140 3404-3410
35. P.H. Eng, G.R. Cardona, M.C. Previti, et al. (2001) Regulation of the sodium iodide symporter by iodide in FRTL-5 cells. Eur J Endocrinol 144 139-144
36. K. Suzuki, S. Lavaroni, A. Mori, et al. (1998) Autoregulation of thyroid-specific gene transcription by thyroglobulin. Proc Natl Acad Sci U S A 95 8251-8256
37. K. Suzuki, A. Mori, J. Saito, et al. (1999) Follicular thyroglobulin suppresses iodide uptake by suppressing expression of the sodium/iodide symporter gene. Endocrinology 140 5422-5430
38. K. Suzuki, A. Mori, S. Lavaroni, et al. (1999) In vivo expression of thyroid transcription factor-1 RNA and its relation to thyroid function and follicular heterogeneity: Identification of follicular thyroglobulin as a feedback suppressor of thyroid transcription factor-1 RNA levels and thyroglobulin synthesis. Thyroid 9 319-331
39. I.E. Royaux, K. Suzuki, A. Mori, et al. (2000) Pendrin, the protein encoded by the Pendred’s syndrome gene (PDS), is an apical porter of iodide in the thyroid and is regulated by thyroglobulin in FRTL-5 cells. Endocrinology 141 839-845
40. K. Suzuki and L.D. Kohn (2006) Differential regulation of apical and basal iodide transporters in the thyroid by thyroglobulin. J Endocrinol 189 247-255
41. S.J. Weiss, N.J. Philp and E.F. Grollman (1984) Effect of thyrotropin on iodide efflux in FRTL-5 cells mediated by Ca 2+. Endocrinology 114 1108-1113
42. M. Nilsson, U. Bjorkman, R. Ekholm and L.E. Ericson (1990) Iodide transport in primary cultured thyroid follicle cells: Evidence of a TSH-regulated channel mediating iodide efflux selectively across the apical domain of the plasma membrane. Eur J Cell Biol 52 270-281
43. M. Nilsson, U. Bjorkman, R. Ekholm and L.E. Ericson (1992) Polarized efflux of iodide in porcine thyrocytes occurs via a cAMP-regulated iodide channel in the apical plasma membrane. Acta Endocrinol (Copenh) 126 67-74
44. P. Golstein, M. Abramow, J.E. Dumont and R. Beauwens (1992) The iodide channel of the thyroid: A plasma membrane vesicle study. Am J Physiol 263 C590-597
45. L.A. Everett, B. Glaser, J.C. Beck, et al. (1997) Pendred’s syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat Genet 17 411-422
46. D.A. Scott, R. Wang, T.M. Kreman, et al. (1999) The Pendred’s syndrome gene encodes a chloride-iodide transport protein. Nature Genet 21 440-443
47. J.P. Taylor, R.A. Metcalfe, P.F. Watson, et al. (2002) Mutations of the PDS gene, encoding pendrin, are associated with protein mislocalization and loss of iodide efflux: Implications for thyroid dysfunction in Pendred’s syndrome. J Clin Endocrinol Metabol 87 1778-1784
48. A. Yoshida, S. Taniguchi, I. Hisatome, et al. (2002) Pendrin is an iodide-specific apical porter responsible for iodide efflux from thyroid cells. J Clin Endocrinol Metabol 87 3356-3361
49. M.P. Gillam, A. Sidhaye, E.J. Lee, et al. (2004) Functional characterization of pendrin in a polarized cell system: Evidence for pendrin-mediated apical iodide efflux. J Biol Chem 279 13004-13010
50. A.M. Rodriguez, B. Perron, L. Lacroix, et al. (2002) Identification and characterization of a putative human iodide transporter located at the apical membrane of thyrocytes. J Clin Endocrinol Metab 87 3500-3503
51. V. Paroder, S.R. Spencer, M. Paroder, et al. (2006) Na(+)/monocarboxylate transport (SMCT) protein expression correlates with survival in colon cancer: Molecular characterization of SMCT. Proc Natl Acad Sci U S A 103 7270-7275
52. G.R. Fraser, M.E. Morgans and W.R. Trotter (1960) The syndrome of sporadic goitre and congenital deafness. Q J Med 29 279-295
53. G. Medeiros-Neto and J.B. Stanbury (1994) Pendred’s syndrome: Association of congenital deafness with sporadic goiter. G. Medeiros-Neto, J.B. Stanbury (Eds) Inherited Disorders of the Thyroid System Boca Raton, Fla: CRC Press 81-105
54. P. Kopp (2000) Pendred’s syndrome and genetic defects in thyroid hormone synthesis. Rev Endocrinol Metab Dis 1/2 109-121
55. P. Kopp and L. Pesce (2008) Solis-S J: Pendred’s syndrome and iodide transport in the thyroid. Trends Endocrinol 19 260-268
56. L.A. Everett and E.D. Green (1999) A family of mammalian anion transporters and their involvement in human genetic diseases. Hum Mol Genet 8 1883-1891
57. J. Zheng, W. Shen, D.Z. He, et al. (2000) Prestin is the motor protein of cochlear outer hair cells. Nature 405 149-155
58. X.Z. Liu, X.M. Ouyang, X.J. Xia, et al. (2003) Prestin, a cochlear motor protein, is defective in non-syndromic hearing loss. Hum Mol Genet 12 1155-1162
59. V. Porra, F. Bernier-Valentin, S. Trouttet-Masson, et al. (2002) Characterization and semiquantitative analyses of pendrin expressed in normal and tumoral human thyroid tissues. J Clin Endocrinol Metab 87 1700-1707
60. L. Aravind and E.V. Koonin (2001) The STAS domain—a link between anion transporters and antisigma-factor antagonists. Curr Biol 10 R53-R55
61. S.B. Ko, N. Shcheynikov, J.Y. Choi, et al. (2002) A molecular mechanism for aberrant CFTR-dependent HCO(3)(-) transport in cystic fibrosis. EMBO J 21 5662-5672
62. S.B. Ko, W. Zeng, M.R. Dorwart, et al. (2004) Gating of CFTR by the STAS domain of SLC26 transporters. Nat Cell Biol 6 343-350
63. N. Shcheynikov, S.B. Ko, W. Zeng, et al. (2006) Regulatory interaction between CFTR and the SLC26 transporters. Novartis Found Symp 273 177-186
64. J.M. Bidart, C. Mian, V. Lazar, et al. (2000) Expression of pendrin and the Pendred’s syndrome (PDS) gene in human thyroid tissues. J Clin Endocrinol Metab 85 2028-2033
65. L.A. Everett, H. Morsli, D.K. Wu and E.D. Green (1999) Expression pattern of the mouse ortholog of the Pendred’s syndrome gene (Pds) suggests a key role for pendrin in the inner ear. Proc Natl Acad Sci 96 9727-9732
66. I.E. Royaux, I.A. Belyantseva, T. Wu, et al. (2003) Localization and functional studies of pendrin in the mouse inner ear provide insight about the etiology of deafness in Pendred’s syndrome. J Assoc Res Otolaryngol 4 394-404
67. M. Soleimani, T. Greeley, S. Petrovic, et al. (2001) Pendrin: An apical Cl −/OH −/HCO 3 − exchanger in the kidney cortex. Am J Physiol Renal Physiol 280 F356-F364
68. I.E. Royaux, S.M. Wall, L.P. Karniski, et al. (2001) Pendrin, encoded by the Pendred’s syndrome gene, resides in the apical region of renal intercalated cells and mediates bicarbonate secretion. Proc Natl Acad Sci U S A 98 4221-4226
69. S.M. Wall, K.A. Hassell, I.E. Royaux, et al. (2003) Localization of pendrin in mouse kidney. Am J Physiol Renal Physiol 284 F229-241
70. J.M. Bidart, L. Lacroix, D. Evain-Brion, et al. (2000) Expression of Na +/I − symporter and Pendred’s syndrome genes in trophoblast cells. J Clin Endocrinol Metab 85 4367-4372
71. K. Suzuki, I.E. Royaux, L.A. Everett, et al. (2002) Expression of PDS/Pds, the Pendred’s syndrome gene, in endometrium. J Clin Endocrinol Metab 87 938
72. J.A. Rillema and M.A. Hill (2003) Prolactin regulation of the pendrin-iodide transporter in the mammary gland. Am J Physiol Endocrinol Metab 284 E25-28
73. L. Lacroix, C. Mian, B. Caillou, et al. (2001) Na +/I − symporter and Pendred’s syndrome gene and protein expressions in human extra-thyroidal tissues. Eur J Endocrinol 144 297-302
74. C. Mian, L. Lacroix, L. Alzieu, et al. (2001) Sodium iodide symporter and pendrin expression in human thyroid tissues. Thyroid 11 825-830
75. M. Dentice, C. Luongo, A. Elefante, et al. (2005) Pendrin is a novel in vivo downstream target gene of the TTF-1/Nkx-2.1 homeodomain transcription factor in differentiated thyroid cells. Mol Cell Biol 25 10171-10182
76. Solis-S J, Schnyder S, Chen L, Kopp P: Synergistic stimulation of the human PDS/SLC26A4 promoter by PAX8 and TTF-1. Presented at the 77th Annual Meeting of the American Thyroid Association. Phoenix, Ariz, October 2006
77. K. Suzuki, A. Mori, K.J. Ishii, et al. (1999) Activation of target-tissue immune-recognition molecules by double-stranded polynucleotides. Proc Natl Acad Sci U S A 96 2285-2290
78. Solis-S J, Schnyder S, Chen L, Kopp P: Regulation of thyroidal transcripts and the human PDS/SLC26A4 promoter by thyroglobulin. Presented at the 78th Annual Meeting of the American Thyroid Association. New York, October 2007
79. Pesce L, Kopp P: Thyrotropin rapidly regulates pendrin membrane abundance via PKA dependent and PKC independent pathways in rat thyroid cells. Presented at the 78th Annual Meeting of the American Thyroid Association. New York, October 2007
80. D. Russo, S. Bulotta, R. Bruno, et al. (2001) Sodium/iodide symporter (NIS) and pendrin are expressed differently in hot and cold nodules of thyroid toxic multinodular goiter. Eur J Endocrinol 145 591-597
81. F. Arturi, D. Russo, J.M. Bidart, et al. (2001) Expression pattern of the pendrin and sodium/iodide symporter genes in human thyroid carcinoma cell lines and human thyroid tumors. Eur J Endocrinol 145 129-135
82. T. Kondo, N. Nakamura, K. Suzuki, et al. (2003) Expression of human pendrin in diseased thyroids. J Histochem Cytochem 51 167-173
83. A.C. Gerard, C. Daumerie, C. Mestdagh, et al. (2003) Correlation between the loss of thyroglobulin iodination and the expression of thyroid-specific proteins involved in iodine metabolism in thyroid carcinomas. J Clin Endocrinol Metab 88 4977-4983
84. M. Xing, Y. Tokumaru, G. Wu, et al. (2003) Hypermethylation of the Pendred’s syndrome gene SLC26A4 is an early event in thyroid tumorigenesis. Cancer Res 63 2312-2315
85. D.A. Scott, R. Wang, T.M. Kreman, et al. (2000) Functional differences of the PDS gene product are associated with phenotypic variation in patients with Pendred’s syndrome and non-syndromic hearing loss (DFNB4). Hum Mol Genet 9 1709-1715
86. S.M. Wall (2005) Recent advances in our understanding of intercalated cells. Curr Opin Nephrol Hypertens 14 480-484
87. D.A. Scott and L.P. Karniski (2000) Human pendrin expressed in Xenopus laevis oocytes mediates chloride/formate exchange. Am J Cell Physiol 278 C207-C211
88. S. Petrovic, Z. Wang, L. Ma and M. Soleimani (2003) Regulation of the apical Cl − /HCO 3 − exchanger pendrin in rat cortical collecting duct in metabolic acidosis. Am J Physiol Renal Physiol 284 F103-112
89. C.A. Wagner, K.E. Finberg, P.A. Stehberger, et al. (2002) Regulation of the expression of the Cl −/anion exchanger pendrin in mouse kidney by acid-base status. Kidney Int 62 2109-2117
90. J.W. Verlander, K.A. Hassell, I.E. Royaux, et al. (2003) Deoxycorticosterone upregulates PDS (Slc26a4) in mouse kidney: Role of pendrin in mineralocorticoid-induced hypertension. Hypertension 42 356-362
91. J.W. Verlander, Y.H. Kim, W. Shin, et al. (2006) Dietary Cl − restriction upregulates pendrin expression within the apical plasma membrane of type B intercalated cells. Am J Physiol Renal Physiol 291 F833-F839
92. W. Reardon, C.F. OMahoney, R. Trembath, et al. (2000) Enlarged vestibular aqueduct: A radiological marker of Pendred’s syndrome, and mutation of the PDS gene. QJM 93 99-104
93. L.A. Everett, I.A. Belyantseva, K. Noben-Trauth, et al. (2001) Targeted disruption of mouse Pds provides insight about the inner-ear defects encountered in Pendred’s syndrome. Hum Mol Genet 10 153-161
94. P. Wangemann, E.M. Itza, B. Albrecht, et al. (2004) Loss of KCNJ10 protein expression abolishes endocochlear potential and causes deafness in Pendred’s syndrome mouse model. BMC Med 2 30
95. P. Wangemann, K. Nakaya, T. Wu, et al. (2007) Loss of cochlear HCO 3 − secretion causes deafness via endolymphatic acidification and inhibition of Ca 2+ reabsorption in a Pendred’s syndrome mouse model. Am J Physiol Renal Physiol 292 F1345-1353
96. K. Nakaya, D.G. Harbidge, P. Wangemann, et al. (2007) Lack of pendrin HCO3− transport elevates vestibular endolymphatic [Ca 2+] by inhibition of acid-sensitive TRPV5 and TRPV6 channels. Am J Physiol Renal Physiol 292 F1314-1321
97. E. Sato, T. Nakashima, Y. Miura, et al. (2001) Phenotypes associated with replacement of His by Arg in the Pendred’s syndrome gene. Eur J Endocrinol 145 697-703
98. J. Wolff (2005) What is the role of pendrin? Thyroid 15 346-348
99. F.M. Mendive, C.M. Rivolta, C.M. Moya, et al. (2001) Genomic organization of the human thyroglobulin gene: The complete intron-exon structure. Eur J Endocrinol 145 485-496
100. F.M. Mendive, C.M. Rivolta, G. Vassart and H.M. Targovnik (1999) Genomic organization of the 3¢ region of the human thyroglobulin gene. Thyroid 9 903-912
101. C.M. Moya, F.M. Mendive, C.M. Rivolta, et al. (2000) Genomic organization of the 5¢ region of the human thyroglobulin gene. Eur J Endocrinol 143 789-798
102. F. Baas, H. Bikker, A. Geurts van Kessel, et al. (1985) The human thyroglobulin gene: A polymorphic marker localized distal to C-MYC on chromosome 8 band q24. Hum Genet 69 138-143
103. M. Rabin, P.E. Barker, F.H. Ruddle, et al. (1985) Proximity of thyroglobulin and c-myc genes on human chromosome 8. Somat Cell Mol Genet 11 397-402
104. J.L. Berge-Lefranc, G. Cartouzou, M.G. Mattei, et al. (1985) Localization of the thyroglobulin gene by in situ hybridization to human chromosomes. Hum Genet 69 28-31
105. G. Damante and R. Di Lauro (1994) Thyroid-specific gene expression. Biochim Biophys Acta 1218 255-266
106. F. Kambe and H. Seo (1997) Thyroid-specific transcription factors. Endocr J 44 775-784
107. Y. Malthiery and S. Lissitzky (1987) Primary structure of human thyroglobulin deduced from the sequence of its 8448-base complementary DNA. Eur J Biochem 165 491-498
108. S.A. van de Graaf, E. Pauws, J.J. de Vijlder and C.R. Ris-Stalpers (1997) The revised 8307 base pair coding sequence of human thyroglobulin transiently expressed in eukaryotic cells. Eur J Endocrinol 136 508-515
109. S.A. van de Graaf, C. Ris-Stalpers, E. Pauws, et al. (2001) Up to date with human thyroglobulin. J Endocrinol 170 307-321
110. P.S. Kim and P. Arvan (1993) Hormonal regulation of thyroglobulin export from the endoplasmic reticulum of cultured thyrocytes. J Biol Chem 268 4873-4879
111. P. Arvan, P.S. Kim, R. Kuliawat, et al. (1997) Intracellular protein transport to the thyrocyte plasma membrane: Potential implications for thyroid physiology. Thyroid 7 89-105
112. J.T. Dunn and A.D. Dunn (2005) Thyroglobulin: Chemistry, biosynthesis, and proteolysis. L. Braverman, R. Utiger (Eds) Werner and Ingbar’s The Thyroid: A Fundamental and Clinical Text Philadelphia, Lippincott: Williams & Wilkins 91-104
113. F. Molina, M. Bouanani, B. Pau and C. Granier (1996) Characterization of the type-1 repeat from thyroglobulin, a cysteine-rich module found in proteins from different families. Eur J Biochem 240 125-133
114. M. Yamashita and S. Konagaya (1996) A novel cysteine protease inhibitor of the egg of chum salmon, containing a cysteine-rich thyroglobulin-like motif. J Biol Chem 271 1282-1284
115. L. Mercken, M.J. Simons, G. De Martynoff, et al. (1985) Presence of hormonogenic and repetitive domains in the first 930 amino acids of bovine thyroglobulin as deduced from the cDNA sequence. Eur J Biochem 147 59-64
116. S. Swillens, M. Ludgate, L. Mercken, et al. (1986) Analysis of sequence and structure homologies between thyroglobulin and acetylcholinesterase: Possible functional and clinical significance. Biochem Biophys Res Commun 137 142-148
117. J. Parma, D. Christophe, V. Pohl and G. Vassart (1987) Structural organization of the 5¢ region of the thyroglobulin gene. Evidence for intron loss and “exonization” during evolution. J Mol Biol 196 769-779
118. S.X. Yang, H.G. Pollock and A.B. Rawitch (1996) Glycosylation in human thyroglobulin: Location of the N-linked oligosaccharide units and comparison with bovine thyroglobulin. Arch Biochem Biophys 327 61-70
119. S. Sakurai, L. Fogelfeld and A.B. Schneider (1991) Anionic carbohydrate groups of human thyroglobulin containing both phosphate and sulfate. Endocrinology 129 915-920
120. H. Blode, T. Heinrich and H. Diringe (1990) : A quantitative assay for tyrosine sulfation and tyrosine phosphorylation in peptides. Biol Chem Hoppe Seyler 371 145-151
121. N. Venot, M.C. Nlend, D. Cauvi and O. Chabaud (2002) The hormonogenic tyrosine 5 of porcine thyroglobulin is sulfated. Biochem Biophys Res Commun 298 193-197
122. L. Lamas, P.C. Anderson, J.W. Fox and J.T. Dunn (1989) Consensus sequences for early iodination and hormonogenesis in human thyroglobulin. J Biol Chem 264 13541-13545
123. A.D. Dunn, C.M. Corsi, H.E. Myers and J.T. Dunn (1998) Tyrosine 130 is an important outer ring donor for thyroxine formation in thyroglobulin. J Biol Chem 273 25223-25229
124. M. Marino and R.T. McCluskey (2000) Role of thyroglobulin endocytic pathways in the control of thyroid hormone release. Am J Physiol Cell Physiol 279 C1295-1306
125. M. Marino, A. Pinchera, R.T. McCluskey and L. Chiovato (2001) Megalin in thyroid physiology and pathology. Thyroid 11 47-56
126. V. Herzog (1983) Transcytosis in thyroid follicle cells. J Cell Biol 97 607-617
127. L. Druetta, H. Bornet, G. Sassolas and B. Rousset (1999) Identification of thyroid hormone residues on serum thyroglobulin: A clue to the source of circulating thyroglobulin in thyroid diseases. Eur J Endocrinol 140 457-467
128. O. Isozaki, L.D. Kohn, C.A. Kozak and S. Kimura (1989) Thyroid peroxidase: Rat cDNA sequence, chromosomal localization in mouse, and regulation of gene expression by comparison to thyroglobulin in rat FRTL-5 cells. Mol Endocrinol 3 1681-1692
129. C.M. Gerard, A. Lefort, F. Libert, et al. (1988) Transcriptional regulation of the thyroperoxydase gene by thyrotropin and forskolin. Mol Cell Endocrinol 60 239-242
130. M. Zannini, H. Francis-Lang, D. Plachov and R. Di Lauro (1992) Pax-8, a paired domain-containing protein, binds to a sequence overlapping the recognition site of a homeodomain and activates transcription from two thyroid-specific promoters. Mol Cell Biol 12 4230-4241
131. T. Di Palma, R. Nitsch, A. Mascia, et al. (2003) The paired domain-containing factor Pax8 and the homeodomain-containing factor TTF-1 directly interact and synergistically activate transcription. J Biol Chem 278 3395-3402
132. B. Corvilain, J. van Sande, E. Laurent and J.E. Dumont (1991) The H 2O 2 generating system modulates protein iodination and the activity of the pentose phosphate pathway in dog thyroid. Endocrinology 128 779-785
133. R. Ekholm (1981) Iodination of thyroglobulin. An intracellular or extracellular process? Mol Cell Endocrinol 24 141-163
134. U. Bjorkman and R. Ekholm (1984) Generation of H 2O 2 in isolated porcine thyroid follicles. Endocrinology 115 392-398
135. A. Virion, J.L. Michot, D. Deme, et al. (1984) NADPH-dependent H 2O 2 generation and peroxidase activity in thyroid particular fraction. Mol Cell Endocrinol 36 95-105
136. Y. Nakamura, S. Ogihara and S. Ohtaki (1987) Activation by ATP of calcium-dependent NADPH-oxidase generating hydrogen peroxide in thyroid plasma membranes. J Biochem 102 1121-1132
137. C. Dupuy, J. Kaniewski, D. Deme, et al. (1989) NADPH-dependent H 2O 2 generation catalyzed by thyroid plasma membranes. Studies with electron scavengers. Eur J Biochem 185 597-603
138. A.M. Leseney, D. Deme, O. Legue, et al. (1999) Biochemical characterization of a Ca 2+/NAD(P)H-dependent H 2O 2 generator in human thyroid tissue. Biochimie 81 373-380
139. D. Dème, J. Doussiere, V. De Sandro, et al. (1994) The Ca 2+/NADPH-dependent H 2O 2 generator in thyroid plasma membrane: Inhibition by diphenyleneiodonium. Biochem J 301 75-81
140. Y. Gorin, R. Ohayon, D.P. Carvalho, et al. (1996) Solubilization and characterization of a thyroid Ca 2+-dependent and NADPH-dependent K 3Fe(CN) 6 reductase. Relationship with the NADPH-dependent H 2O 2-generating system. Eur J Biochem 240 807-814
141. D. Dème, A. Virion, N.A. Hammou and J. Pommier (1985) NADPH-dependent generation of H 2O 2 in a thyroid particulate fraction requires Ca 2+. FEBS Lett 186 107-110
142. E. Raspé, E. Laurent, B. Corvilain, et al. (1991) Control of the intracellular Ca 2+-concentration and the inositol phosphate accumulation in dog thyrocyte primary culture: Evidence for different kinetics of Ca 2+-phosphatidylinositol cascade activation and for involvement in the regulation of H 2O 2 production. J Cell Physiol 146 242-250
143. E. Raspé and J.E. Dumont (1995) Tonic modulation of dog thyrocyte H 2O 2 generation and I − uptake by thyrotropin through the cyclic adenosine 3¢,5¢-monophosphate cascade. Endocrinology 136 965-973
144. C. Dupuy, R. Ohayon, A. Valent, et al. (1999) Purification of a novel flavoprotein involved in the thyroid NADPH oxidase. Cloning of the porcine and human cDNAs. J Biol Chem 274 37265-37269
145. X. De Deken, D. Wang, M.C. Many, et al. (2000) Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. J Biol Chem 275 23227-23233
146. W.A. Edens, L. Sharling, G. Cheng, et al. (2001) Tyrosine cross-linking of extracellular matrix is catalyzed by Duox, a multidomain oxidase/peroxidase with homology to the phagocyte oxidase subunit gp91phox. J Cell Biol 154 879-891
147. J.C. Moreno, E. Pauws, A.H. van Kampen, et al. (2001) Cloning of tissue-specific genes using serial analysis of gene expression and a novel computational substraction approach. Genomics 75 70-76
148. X. De Deken, D. Wang, J.E. Dumont and F. Miot (2002) Characterization of ThOX proteins as components of the thyroid H 2O 2-generating system. Exp Cell Res 273 187-196
149. L. Yu, M.T. Quinn, A.R. Cross and M.C. Dinauer (1998) Gp91(phox) is the heme binding subunit of the superoxide-generating NADPH oxidase. Proc Natl Acad Sci U S A 95 7993-7998
150. Y.A. Suh, R.S. Arnold, B. Lassegue, et al. (1999) Cell transformation by the superoxide-generating oxidase Mox1. Nature 401 79-82
151. B. Corvilain, E. Laurent, M. Lecomte, et al. (1994) Role of the cyclic adenosine 3¢,5¢ -monophosphate and the phosphatidylinositol-Ca 2+ cascades in mediating the effects of thyrotropin and iodide on hormone synthesis and secretion in human thyroid slices. J Clin Endocrinol Metab 79 152-159
152. B. Caillou, C. Dupuy, L. Lacroix, et al. (2001) Expression of reduced nicotinamide adenine dinucleotide phosphate oxidase (ThoX, LNOX, Duox) genes and proteins in human thyroid tissues. J Clin Endocrinol Metab 86 3351-3358
153. C. Dupuy, M. Pomerance, R. Ohayon, et al. (2000) Thyroid oxidase (THOX2) gene expression in the rat thyroid cell line FRTL-5. Biochem Biophys Res Commun 277 287-292
154. B. Corvilain, J. Van Sande and J.E. Dumont (1988) Inhibition by iodide of iodide binding to proteins: The “Wolff-Chaikoff” effect is caused by inhibition of H 2O 2 generation. Biochem Biophys Res Commun 154 1287-1292
155. S. Morand, M. Chaaraoui, J. Kaniewski, et al. (2003) Effect of iodide on nicotinamide adenine dinucleotide phosphate oxidase activity and Duox2 protein expression in isolated porcine thyroid follicles. Endocrinology 144 1241-1248
156. L. Lacroix, M. Nocera, C. Mian, et al. (2001) Expression of nicotinamide adenine dinucleotide phosphate oxidase flavoprotein DUOX genes and proteins in human papillary and follicular thyroid carcinomas. Thyroid 11 1017-1023
157. R. Kuliawat, M.P. Lisanti and P. Arvan (1995) Polarized distribution and delivery of plasma membrane proteins in thyroid follicular epithelial cells. J Biol Chem 270 2478-2482
158. H. Grasberger and S. Refetoff (2006) Identification of the maturation factor for dual oxidase. Evolution of an eukaryotic operon equivalent. J Biol Chem 281 18269-18272
159. H. Grasberger, X. De Deken, F. Miot, et al. (2007) Missense mutations of dual oxidase 2 (DUOX2) implicated in congenital hypothyroidism have impaired trafficking in cells reconstituted with DUOX2 maturation factor. Mol Endocrinol 21 1408-1421
160. C. Dupuy, D. Deme, J. Kaniewski, et al. (1988) Ca 2+ regulation of thyroid NADPH-dependent H 2O 2 generation. FEBS Lett 233 74-78
161. C. Dupuy, A. Virion, R. Ohayon, et al. (1991) Mechanism of hydrogen peroxide formation catalyzed by NADPH oxidase in thyroid plasma membrane. J Biol Chem 266 3739-3743
162. D.P. Carvalho, C. Dupuy, Y. Gorin, et al. (1996) The Ca 2+- and reduced nicotinamide adenine dinucleotide phosphate-dependent hydrogen peroxide generating system is induced by thyrotropin in porcine thyroid cells. Endocrinology 137 1007-1012
163. Y. Gorin, A.M. Leseney, R. Ohayon, et al. (1997) Regulation of the thyroid NADPH-dependent H 2O 2 generator by Ca 2+: Studies with phenylarsine oxide in thyroid plasma membrane. Biochem J 321 383-388
164. U. Bjorkman and R. Ekholm (1988) Accelerated exocytosis and H 2O 2 generation in isolated thyroid follicles enhance protein iodination. Endocrinology 122 488-494
165. U. Bjorkman and R. Ekholm (1992) Hydrogen peroxide generation and its regulation in FRTL-5 and porcine thyroid cells. Endocrinology 130 393-399
166. R. Ohayon, J.M. Boeynaems, J.C. Braekman, et al. (1994) Inhibition of thyroid NADPH-oxidase by 2-iodohexadecanal in a cell-free system. Mol Cell Endocrinol 99 133-141
167. V. Panneels, H. Van den Bergen, C. Jacoby, et al. (1994) Inhibition of H 2O 2 production by iodoaldehydes in cultured dog thyroid cells. Mol Cell Endocrinol 102 167-176
168. B. Corvilain, L. Collyn, J. van Sande and J.E. Dumont (2000) Stimulation by iodide of H 2O 2 generation in thyroid slices from several species. Am J Physiol Endocrinol Metab 278 E692-699
169. A. Taurog (1996) Hormone synthesis: Thyroid iodine metabolism. L. Braverman, R. Utiger (Eds) Werner and Ingbar’s The Thyroid: A Fundamental and Clinical Text Philadelphia: Lippincott-Raven 47-81
170. S. Kimura, T. Kotani, O.W. McBride, et al. (1987) Human thyroid peroxidase: Complete cDNA and protein sequence, chromosome mapping, and identification of two alternately spliced mRNAs. Proc Natl Acad Sci U S A 84 5555-5559
171. J.J. de Vijlder, C. Dinsart, F. Libert, et al. (1988) Regional localization of the gene for thyroid peroxidase to human chromosome 2pter-p12. Cytogenet Cell Genet 47 170-172
172. S. Kimura, Y.S. Hong, T. Kotani, et al. (1989) Structure of the human thyroid peroxidase gene: Comparison and relationship to the human myeloperoxidase gene. Biochemistry 28 4481-4489
173. Y. Nagayama, P. Seto and B. Rapoport (1990) Characterization, by molecular cloning, of smaller forms of thyroid peroxidase messenger ribonucleic acid in human thyroid cells as alternatively spliced transcripts. J Clin Endocrinol Metab 71 384-390
174. M. Ferrand, V. Le Fourn and J.L. Franc (2003) Increasing diversity of human thyroperoxidase generated by alternative splicing characterized by molecular cloning of new transcripts with single- and multispliced mRNAs. J Biol Chem 278 3793-3800
175. P. Niccoli, L. Fayadat, V. Panneels, et al. (1997) Human thyroperoxidase in its alternatively spliced form (TPO2) is enzymatically inactive and exhibits changes in intracellular processing and trafficking. J Biol Chem 272 29487-29492
176. S. Nagataki, H. Uchimura, Y. Masuyama and K. Nakao (1973) Thyrotropin and thyroidal peroxidase activity. Endocrinology 92 363-371
177. K. Yamamoto and L.J. DeGroot (1974) Peroxidase and NADPH-cytochrome C reductase activity during thyroid hyperplasia and involution. Endocrinology 95 606-612
178. A. Nagasaka and H. Hidaka (1980) Quantitative modulation of thyroid iodide peroxidase by thyroid stimulating hormone. Biochem Biophys Res Commun 96 1143-1149
179. G. Chazenbalk, R.P. Magnusson and B. Rapoport (1987) Thyrotropin stimulation of cultured thyroid cells increases steady state levels of the messenger ribonucleic acid for thyroid peroxidase. Mol Endocrinol 1 913-917
180. G. Damante, G. Chazenbalk, D. Russo, et al. (1989) Thyrotropin regulation of thyroid peroxidase messenger ribonucleic acid levels in cultured rat thyroid cells: Evidence for the involvement of a nontranscriptional mechanism. Endocrinology 124 2889-2894
181. Y. Nagayama, S. Yamashita, H. Hirayu, et al. (1989) Regulation of thyroid peroxidase and thyroglobulin gene expression by thyrotropin in cultured human thyroid cells. J Clin Endocrinol Metab 68 1155-1159
182. C.M. Gerard, A. Lefort, D. Christophe, et al. (1989) Control of thyroperoxidase and thyroglobulin transcription by cAMP: Evidence for distinct regulatory mechanisms. Mol Endocrinol 3 2110-2118
183. M.J. Abramowicz, G. Vassart and D. Christophe (1990) Thyroid peroxidase gene promoter confers TSH responsiveness to heterologous reporter genes in transfection experiments. Biochem Biophys Res Commun 166 1257-1264
184. P. Aza-Blanc, R. Di Lauro and P. Santisteban (1993) Identification of a cis-regulatory element and a thyroid-specific nuclear factor mediating the hormonal regulation of rat thyroid peroxidase promoter activity. Mol Endocrinol 7 1297-1306
185. M.J. Abramowicz, G. Vassart and D. Christophe (1992) Functional study of the human thyroid peroxidase gene promoter. Eur J Biochem 203 467-473
186. S. Miccadei, R. De Leo, E. Zammarchi, et al. (2002) The synergistic activity of thyroid transcription factor 1 and Pax 8 relies on the promoter/enhancer interplay. Mol Endocrinol 16 837-846
187. L. Ortiz, P. Aza-Blanc, M. Zannini, et al. (1999) The interaction between the forkhead thyroid transcription factor TTF-2 and the constitutive factor CTF/NF-1 is required for efficient hormonal regulation of the thyroperoxidase gene transcription. J Biol Chem 274 15213-15221
188. R. De Leo, S. Miccadei, E. Zammarchi and D. Civitareale (2000) Role for p300 in Pax 8 induction of thyroperoxidase gene expression. J Biol Chem 275 34100-34105
189. F. Kikkawa, F.J. Gonzalez and S. Kimura (1990) Characterization of a thyroid-specific enhancer located 5.5 kilobase pairs upstream of the human thyroid peroxidase gene. Mol Cell Biol 10 6216-6224
190. K. Mizuno, F.J. Gonzalez and S. Kimura (1991) Thyroid-specific enhancer-binding protein (T/EBP): cDNA cloning, functional characterization, and structural identity with thyroid transcription factor TTF-1. Mol Cell Biol 11 4927-4933
191. C. Esposito, S. Miccadei, A. Saiardi and D. Civitareale (1998) PAX 8 activates the enhancer of the human thyroperoxidase gene. Biochem J 331 37-40
192. K.S. Collison, J.P. Banga, P.S. Barnett, et al. (1989) Activation of the thyroid peroxidase gene in human thyroid cells: Effect of thyrotrophin, forskolin and phorbol ester. J Mol Endocrinol 3 1-5
193. K. Ashizawa, S. Yamashita, Y. Nagayama, et al. (1989) Interferon-gamma inhibits thyrotropin-induced thyroidal peroxidase gene expression in cultured human thyrocytes. J Clin Endocrinol Metab 69 475-477
194. K. Ashizawa, S. Yamashita, T. Tobinaga, et al. (1989) Inhibition of human thyroid peroxidase gene expression by interleukin 1. Acta Endocrinol (Copenh) 121 465-469
195. F. Cetani, S. Costagliola, M. Tonacchera, et al. (1995) The thyroperoxidase doublet is not produced by alternative splicing. Mol Cell Endocrinol 115 125-132
196. A. Taurog, M.L. Dorris, N. Yokoyama and C. Slaughter (1990) Purification and characterization of a large, tryptic fragment of human thyroid peroxidase with high catalytic activity. Arch Biochem Biophys 278 333-341
197. N. Yokoyama and A. Taurog (1988) Porcine thyroid peroxidase: Relationship between the native enzyme and an active, highly purified tryptic fragment. Mol Endocrinol 2 838-844
198. D. Foti, K.D. Kaufman, G.D. Chazenbalk and B. Rapoport (1990) Generation of a biologically active, secreted form of human thyroid peroxidase by site-directed mutagenesis. Mol Endocrinol 4 786-791
199. A.B. Rawitch, H.G. Pollock and S.X. Yang (1993) Thyroglobulin glycosylation: Location and nature of the N-linked oligosaccharide units in bovine thyroglobulin. Arch Biochem Biophys 300 271-279
200. A. Taurog and M. Wall (1998) Proximal and distal histidines in thyroid peroxidase: Relation to the alternatively spliced form, TPO-2. Thyroid 8 185-191
201. L. De Gioia, E. Ghibaudi, E. Laurenti, et al. (1996) A theoretical three-dimensional model for lactoperoxidase and eosinophil peroxidase, built on the scaffold of the myeloperoxidase X-ray structure. J Biol Inorg Chem 1 476-485
202. A. Taurog (1999) Molecular evolution of thyroid peroxidase. Biochimie 81 557-562
203. R.P. Magnusson, J. Gestautas, A. Taurog and B. Rapoport (1987) Molecular cloning of the structural gene for porcine thyroid peroxidase. J Biol Chem 262 13885-13888
204. K.R. Johnson, W.M. Nauseef, A. Care, et al. (1987) Characterization of cDNA clones for human myeloperoxidase: Predicted amino acid sequence and evidence for multiple mRNA species. Nucleic Acids Res 15 2013-2028
205. K. Morishita, N. Kubota, S. Asano, et al. (1987) Molecular cloning and characterization of cDNA for human myeloperoxidase. J Biol Chem 262 3844-3851
206. S. Kimura and M. Ikeda-Saito (1988) Human myeloperoxidase and thyroid peroxidase, two enzymes with separate and distinct physiological functions, are evolutionarily related members of the same gene family. Proteins 3 113-120
207. T.J. Dull, C. Uyeda, A.D. Strosberg, et al. (1990) Molecular cloning of cDNAs encoding bovine and human lactoperoxidase. DNA Cell Biol 9 499-509
208. C. Kiser, C.K. Caterina, J.A. Engle, et al. (1996) Cloning and sequence analysis of the human salivary peroxidase-encoding cDNA. Gene 173 261-264
209. K. Sakamaki, M. Tomonaga, K. Tsukui and S. Nagata (1989) Molecular cloning and characterization of a chromosomal gene for human eosinophil peroxidase. J Biol Chem 264 16828-16836
210. F. Libert, J. Ruel, M. Ludgate, et al. (1987) Thyroperoxidase, an auto-antigen with a mosaic structure made of nuclear and mitochondrial gene modules. Embo J 6 4193-4196
211. J. Zeng and R.E. Fenna (1992) X-ray crystal structure of canine myeloperoxidase at 3 Å resolution. J Mol Biol 226 185-207
212. T.J. Fiedler, C.A. Davey and R.E. Fenna (2000) X-ray crystal structure and characterization of halide-binding sites of human myeloperoxidase at 1.8 Å resolution. J Biol Chem 275 11964-11971
213. M. Blair-Johnson, T. Fiedler and R. Fenna (2001) Human myeloperoxidase: structure of a cyanide complex and its interaction with bromide and thiocyanate substrates at 1.9 A resolution. Biochemistry 40 13990-13997
214. M. Nilsson, J. Molne, F.A. Karlsson and L.E. Ericson (1987) Immunoelectron microscopic studies on the cell surface location of the thyroid microsomal antigen. Mol Cell Endocrinol 53 177-186
215. A. Pinchera, S. Mariotti, L. Chiovato, et al. (1987) Cellular localization of the microsomal antigen and the thyroid peroxidase antigen. Acta Endocrinol 281 57-62
216. U. Bjorkman, R. Ekholm and L.E. Ericson (1978) Effects of thyrotropin on thyroglobulin exocytosis and iodination in the rat thyroid gland. Endocrinology 102 460-470
217. L. Chiovato, P. Vitti, A. Lombardi, et al. (1985) Expression of the microsomal antigen on the surface of continuously cultured rat thyroid cells is modulated by thyrotropin. J Clin Endocrinol Metab 61 12-16
218. X. Zhang and P. Arvan (2000) Cell type-dependent differences in thyroid peroxidase cell surface expression. J Biol Chem 275 31946-31953
219. C. Penel, D. Gruffat, C. Alquier, et al. (1998) Thyrotropin chronically regulates the pool of thyroperoxidase and its intracellular distribution: A quantitative confocal microscopic study. J Cell Physiol 174 160-169
220. L. Fayadat, P. Niccoli-Sire, J. Lanet and J.L. Franc (1998) Human thyroperoxidase is largely retained and rapidly degraded in the endoplasmic reticulum. Its N-glycans are required for folding and intracellular trafficking. Endocrinology 139 4277-4285
221. L. Fayadat, S. Siffroi-Fernandez, J. Lanet and J.L. Franc (2000) Degradation of human thyroperoxidase in the endoplasmic reticulum involves two different pathways depending on the folding state of the protein. J Biol Chem 275 15948-15954
222. H. Nakagawa, T. Kotani, S. Ohtaki, et al. (1985) Purification of thyroid peroxidase by monoclonal antibody-assisted immunoaffinity chromatography. Biochem Biophys Res Commun 127 8-14
223. S. Ohtaki, T. Kotani and Y. Nakamura (1986) Characterization of human thyroid peroxidase purified by monoclonal antibody-assisted chromatography. J Clin Endocrinol Metab 63 570-576
224. S.M. McLachlan and B. Rapoport (1992) The molecular biology of thyroid peroxidase: Cloning, expression and role as autoantigen in autoimmune thyroid disease. Endocr Rev 13 192-206
225. J. Guo, S.M. McLachlan, S. Hutchison and B. Rapoport (1998) The greater glycan content of recombinant human thyroid peroxidase of mammalian than of insect cell origin facilitates purification to homogeneity of enzymatically protein remaining soluble at high concentration. Endocrinology 139 999-1005
226. M. Morrison and G.R. Schonbaum (1976) Peroxidase-catalyzed halogenation. Annu Rev Biochem 45 861-888
227. R.P. Magnusson, A. Taurog and M.L. Dorris (1984) Mechanisms of thyroid peroxidase- and lactoperoxidase-catalyzed reactions involving iodide. J Biol Chem 259 13783-13790
228. R.P. Magnusson, A. Taurog and M.L. Dorris (1984) Mechanism of iodide-dependent catalatic activity of thyroid peroxidase and lactoperoxidase. J Biol Chem 259 197-205
229. H.B. Dunford and I.M. Ralston (1983) On the mechanism of iodination of tyrosine. Biochem Biophys Res Commun 116 639-643
230. W. Sun and H.B. Dunford (1993) Kinetics and mechanism of the peroxidase-catalyzed iodination of tyrosine. Biochemistry 32 1324-1331
231. D.R. Morris and L.P. Hager (1966) Mechanism of the inhibition of enzymatic halogenation by antithyroid agents. J Biol Chem 241 3582-3589
232. S. Ohtaki, H. Nakagawa, S. Kimura and I. Yamazaki (1981) Analyses of catalytic intermediates of hog thyroid peroxidase during its iodinating reaction. J Biol Chem 256 805-810
233. M. Nakamura, I. Yamazaki, H. Nakagawa and S. Ohtaki (1983) Steady state kinetics and regulation of thyroid peroxidase-catalyzed iodination. J Biol Chem 258 3837-3842
234. S. Ohtaki, H. Nakagawa, M. Nakamura and T. Kotani (1996) Thyroid peroxidase: Experimental and clinical integration. Endocr J 43 1-14
235. J.H. Dawson (1988) Probing structure-function relations in heme-containing oxygenases and peroxidases. Science 240 433-439
236. Y. Malthiery, C. Marriq, J.L. Berge-Lefranc, et al. (1989) Thyroglobulin structure and function: Recent advances. Biochimie 71 195-209
237. S. Xiao, M.L. Dorris, A.B. Rawitch and A. Taurog (1996) Selectivity in tyrosyl iodination sites in human thyroglobulin. Arch Biochem Biophys 334 284-294
238. A. Taurog, M.L. Dorris and D.R. Doerge (1996) Mechanism of simultaneous iodination and coupling catalyzed by thyroid peroxidase. Arch Biochem Biophys 330 24-32
239. J.M. Gavaret, J. Nunez and H.J. Cahnmann (1980) Formation of dehydroalanine residues during thyroid hormone synthesis in thyroglobulin. J Biol Chem 255 5281-5285
240. P.S. Kim, J.T. Dunn and D.L. Kaiser (1984) Similar hormone-rich peptides from thyroglobulins of five vertebrate classes. Endocrinology 114 369-374
241. F. Bernier-Valentin, Z. Kostrouch, R. Rabilloud, et al. (1990) Coated vesicles from thyroid cells carry iodinated thyroglobulin molecules. First indication for an internalization of the thyroid prohormone via a mechanism of receptor-mediated endocytosis. J Biol Chem 265 17373-17380
242. Z. Kostrouch, F. Bernier-Valentin, Y. Munari-Silem, et al. (1993) Thyroglobulin molecules internalized by thyrocytes are sorted in early endosomes and partially recycled back to the follicular lumen. Endocrinology 132 2645-2653
243. A.D. Dunn, H.E. Crutchfield and J.T. Dunn (1991) Thyroglobulin processing by thyroidal proteases. Major sites of cleavage by cathepsins B, D, and L. J Biol Chem 266 20198-20204
244. A.D. Dunn, H.E. Crutchfield and J.T. Dunn (1991) Proteolytic processing of thyroglobulin by extracts of thyroid lysosomes. Endocrinology 128 3073-3080
245. T. Tokuyama, M. Yoshinari, A.B. Rawitch and A. Taurog (1987) Digestion of thyroglobulin with purified thyroid lysosomes: Preferential release of iodoamino acids. Endocrinology 121 714-721
246. A.D. Dunn, H.E. Myers and J.T. Dunn (1996) The combined action of two thyroidal proteases releases T4 from the dominant hormone-forming site of thyroglobulin. Endocrinology 137 3279-3285
247. W. Visser, E. Friesema, J. Jansen and T. Visser (2008) Thyroid hormone transport in and out of cells. Trends Endocrinol Metab 19 50-56
248. J. Roche, R. Michel, O. Michel and S. Lissitzky (1952) Sur la déshalgénation enzymatique des iodotyrosines par le corps thyroïde et sur son role physiologique. [Enzymatic dehalogenation of iodotyrosine by thyroid tissue. on its physiological role.] Biochim Biophys Acta 9 161-169
249. J.C. Moreno (2003) Identification of novel genes involved in congenital hypothyroidism using serial analysis of gene expression. Horm Res 60 96-102
250. J.C. Moreno, W. Klootwijk, H. van Toor, et al. (2008) Mutations in the iodotyrosine deiodinase gene and hypothyroidism. N Engl J Med 358 1856-1859
251. I.N. Rosenberg and A. Goswami (1979) Purification and characterization of a flavoprotein from bovine thyroid with iodotyrosine deiodinase activity. J Biol Chem 254 12318-12325
252. I.N. Rosenberg (1970) Purification of iodotyrosine deiodinase from bovine thyroid. Metabolism 19 785-798
253. P. Kopp (2008) Reduce, recycle, reuse—iodotyrosine deiodinase in thyroid iodide metabolism. N Engl J Med 358 1856-1859
254. M.P. Gillam and P. Kopp (2001) Genetic regulation of thyroid development. Curr Opin Pediatr 13 358-363
255. G. Van Vliet (2003) Development of the thyroid gland: Lessons from congenitally hypothyroid mice and men. Clin Genet 63 445-455
256. M. De Felice and R. Di Lauro (2004) Thyroid development and its disorders: Genetics and molecular mechanisms. Endocr Rev 25 722-746
257. J. Wolff (1983) Congenital goiter with defective iodide transport. Endocr Rev 4 240-254
258. H. Fujiwara, K. Tatsumi, K. Miki, et al. (1997) Congenital hypothyroidism caused by a mutation in the Na +/I - symporter. Nat Genet 16 124-125
259. O. Dohan, Z. Baloch, Z. Banrevi, et al. (2001) Predominant intracellular overexpression of the Na +/I − symporter (NIS) in a large sampling of thyroid cancer cases. J Clin Endocrinol Metab 86 2697-2700
260. M.D. Reed-Tsur, A. De la Vieja, C.S. Ginter and N. Carrasco (2008) Molecular characterization of V59E NIS, a Na+/I − symporter mutant that causes congenital I − transport defect. Endocrinology 149 3077-3084
261. O. Levy, C.S. Ginter, A. De la Vieja, et al. (1998) Identification of a structural requirement for thyroid Na +/I − symporter (NIS) function from analysis of a mutation that causes human congenital hypothyroidism. FEBS Lett 429 36-40
262. J. Pohlenz, L. Duprez, R.E. Weiss, et al. (2000) Failure of membrane targeting causes the functional defect of two mutant sodium iodide symporters. J Clin Endocrinol Metab 85 2366-2369
263. G.R. Fraser (1965) Association of congenital deafness with goitre (Pendred’s syndrome). Ann Hum Genet 28 201-249
264. M.E. Morgans and W.R. Trotter (1958) Association of congenital deafness with goitre: The nature of the thyroid defect. Lancet 1 607-609
265. B. Coyle, W. Reardon, J.A. Herbrick, et al. (1998) Molecular analysis of the PDS gene in Pendred’s syndrome (sensorineural hearing loss and goitre). Hum Mol Genet 7 1105-1112
266. P. Van Hauwe, L.A. Everett, P. Coucke, et al. (1998) Two frequent missense mutations in Pendred’s syndrome. Hum Mol Genet 7 1099-1104
267. L. Fugazzola, D. Mannavola, N. Cerutti, et al. (2000) Molecular analysis of the Pendred’s syndrome gene and magnetic resonance imaging studies of the inner ear are essential for the diagnosis of true Pendred’s syndrome. J Clin Endocrinol Metab 85 2469-2475
268. O. Gonzalez Trevino, O. Karamanoglu Arseven, C. Ceballos, et al. (2001) Clinical and molecular analysis of three Mexican families with Pendred’s syndrome. Europ J Endocrinol 144 1-9
269. H.-J. Park, S. Shaukat, X.-Z. Liu, et al. (2003) Origins and frequencies of SLC26A4 (PDS) mutations in east and south Asians: Global implications for the epidemiology of deafness. J Med Genet 40 242-248
270. K. Tsukamoto, H. Suzuki, D. Harada, et al. (2003) Distribution and frequencies of PDS (SLC26A4) mutations in Pendred’s syndrome and nonsyndromic hearing loss associated with enlarged vestibular aqueduct: A unique spectrum of mutations in Japanese. Eur J Hum Genet 24 24
271. P. Rotman-Pikielny, K. Hirschberg, P. Maruvada, et al. (2002) Retention of pendrin in the endoplasmic reticulum is a major mechanism for Pendred’s syndrome. Hum Mol Genet 11 2625-2633
272. L.R. Nilsson, N. Borgfors, I. Gamstorp, et al. (1964) Non-endemic goitre and deafness. Acta Paed 53 117-131
273. T. Ieiri, P. Cochaux, H.M. Targovnik, et al. (1991) A 3¢ splice site mutation in the thyroglobulin gene responsible for congenital goiter with hypothyroidism. J Clin Invest 88 1901-1905
274. J. Vono-Toniolo, C.M. Rivolta, H.M. Targovnik, et al. (2005) Naturally occurring mutations in the thyroglobulin gene. Thyroid 15 1021-1033
275. G. Medeiros-Neto, H.M. Targovnik and G. Vassart (1993) Defective thyroglobulin synthesis and secretion causing goiter and hypothyroidism. Endocr Rev 14 165-183
276. A. Hishinuma, S. Fukata, S. Nishiyama, et al. (2006) Haplotype analysis reveals founder effects of thyroglobulin gene mutations C1058R and C1977S in Japan. J Clin Endocrinol Metab 91 3100-3104
277. P. Caron, C.M. Moya, D. Malet, et al. (2003) Compound heterozygous mutations in the thyroglobulin gene (1143delC and 6725G>A [R2223H]) resulting in fetal goitrous hypothyroidism. J Clin Endocrinol Metab 88 3546-3553
278. P.S. Kim and P. Arvan (1998) Endocrinopathies in the family of endoplasmic reticulum (ER) storage diseases: Disorders of protein trafficking and the role of ER molecular chaperones. Endocr Rev 19 173-202
279. H.M. Targovnik, J. Vono, A.E. Billerbeck, et al. (1995) A 138-nucleotide deletion in the thyroglobulin ribonucleic acid messenger in a congenital goiter with defective thyroglobulin synthesis. J Clin Endocrinol Metab 80 3356-3360
280. G. Medeiros-Neto, P.S. Kim, S.E. Yoo, et al. (1996) Congenital hypothyroid goiter with deficient thyroglobulin. Identification of an endoplasmic reticulum storage disease with induction of molecular chaperones. J Clin Invest 98 2838-2844
281. M.J. Abramowicz, H.M. Targovnik, V. Varela, et al. (1992) Identification of a mutation in the coding sequence of the human thyroid peroxidase gene causing congenital goiter. J Clin Invest 90 1200-1204
282. H. Bikker, T. Vulsma, F. Baas and J.J. de Vijlder (1995) Identification of five novel inactivating mutations in the thyroid peroxidase gene by denaturing gradient gel electrophoresis. Human Mutation 6 9-16
283. S. Pannain, R.E. Weiss, C.E. Jackson, et al. (1999) Two different mutations in the thyroid peroxidase gene of a large inbred Amish kindred: Power and limits of homozygosity mapping. J Clin Endocrinol Metab 84 1061-1071
284. B. Bakker, H. Bikker, T. Vulsma, et al. (2000) Two decades of screening for congenital hypothyroidism in the Netherlands: TPO gene mutations in total iodide organification defects (an update). J Clin Endocrinol Metab 85 3708-3712
285. E.M. McGirr and J.H. Hutchison (1953) Radioactive-iodine studies in non-endemic goitrous cretinism. Lancet 1 1117-1120
286. J.B. Stanbury, A.A. Kassenaar, J.W. Meijer and J. Terpstra (1955) The occurrence of mono- and di-iodotyrosine in the blood of a patient with congenital goiter. J Clin Endocrinol Metab 15 1216-1227
287. G. Medeiros-Neto and J.B. Stanbury (1994) The iodotyrosine deiodinase defect. G. Medeiros-Neto, J.B. Stanbury (Eds) Inherited Disorders of the Thyroid System Boca Raton, Fla: CRC Press 139-159